Sign in
Taking peoplePhase 3

Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation-2 (TELSTAR-2)

Key facts

Who runs it
University of Twente
Where
Belgium and Netherlands20 sites in 2 countriesChoose a country to see its sites
Status
Recruiting
Phase
Phase 3
People taking part
150 people, planned
Started
10 Apr 2025
Expected to end
Dec 2030
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • anti-seizure medication + sedative agent(s)
Record updated
7 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Coma (Glasgow Coma Scale score ≤ 8) after out of hospital cardiac arrest and resuscitation
  • Age ≥ 18 years
  • Continuous EEG with at least eight electrodes started < 24h after return of spontaneous circulation (ROSC)
  • ESE or possible ESE according to the Salzburg and ACNS criteria
  • Possibility to start treatment within three hours after detection of ESE

Who cannot take part

  • EEG background activity prior to the emergence of ESE indicative of extensive irreversible anoxic brain injury
  • Known history of another medical condition with limited life expectancy (< six months)
  • Any progressive brain illness, such as a brain tumor or neurodegenerative disease
  • Reason other than the neurological condition to withdraw treatment
  • Pre-admission Glasgow Outcome Scale score of 3 or lower
  • Follow-up impossible due to logistic reasons, for example not living in the Netherlands or Belgium

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this comparative effectiveness trial is to study electrographic status epilepticus (ESE) treatment in comatose patients after cardiac arrest. The main questions the trial aims to answer are:

Read full original descriptionShow less

* Does ESE treatment improve outcome? * What is the impact of ESE treatment on healthcare costs?

Participants in the the intervention group will receive standard care completed with anti-seizure treatment. The control group will receive standard care without anti-seizure treatment.

The 2 groups in the trial

  • Intervention groupOther group

    Standard care completed with stepwise anti-seizure treatment according to protocols for clinically overt status epilepticus. This consists of a stepwise approach consisting of 3 potential steps. Each next step will be taken as soon as possible (within 30 minutes of ESE first diagnosis or recurrence) if the previous step was insufficiently effective to sustainably suppress ESE.

    Treatment: anti-seizure medication + sedative agent(s)

  • Control groupNo study treatment, for comparison

    Standard care without anti-seizure treatment.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Treatment of ELectrographic STatus Epilepticus After Cardiopulmonary Resuscitation-2: Multicenter Randomised Clinical Trial and Health Economic Evaluation of Anti-seizure Treatment in Comatose Cardiac Arrest Patients With SE on Continuous EEG
Record updated
7 July 2026